Specifically, low expression of NDUFB3 (top 50%) was generally associated with a higher percentage of advanced TNM stage (Figure 3(c)), highlighting that NDUFB3 could be used as a prognostic biomarker for thyroid cancers and implying the possibility that highly expressed NDUFB3 can hinder thyroid cancer progression. This evidence concerns the gene NDUFB3 and thyroid cancer.